middle.news
How TrivarX’s Stabl-Im Acquisition and Veteran Trial Could Transform Diagnostics
8:46am on Friday 30th of January, 2026 AEDT
•
Healthcare
Read Story
How TrivarX’s Stabl-Im Acquisition and Veteran Trial Could Transform Diagnostics
8:46am on Friday 30th of January, 2026 AEDT
Key Points
Acquisition of 100% Stabl-Im stable isotope brain cancer imaging IP
Strong clinical trial results for single-lead ECG depression screening in US veterans
$4.2 million placement led by biotech investor Dr Daniel Tillett
Plans for Phase 1 clinical trials and regulatory engagement in 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE